We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Access to gene therapy for rare diseases when commercialization is not fit for purpose

    Thomas Fox, Juan Bueren, ... Claire Booth in Nature Medicine
    Article 13 February 2023
  2. Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report

    This conference report summarized a full-day workshop, “best practices for the development and fit-for-purpose validation of biomarker methods,”...

    Joel Mathews, Lakshmi Amaravadi, ... Virginia Litwin in AAPS Open
    Article Open access 01 February 2022
  3. Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK

    The COVID-19 pandemic was the first ‘stress test’ to assess whether the current regulations in the United Kingdom (UK) are fit for purpose to develop...

    Rajmeet Jandu, Carl Naraynassamy, Nadarajah Sreeharan in Pharmaceutical Medicine
    Article 28 July 2022
  4. A Fit-for-Purpose Method to Measure Circulating Levels of the mRNA Component of a Liposomal-Formulated Individualized Neoantigen-Specific Therapy for Cancer

    Abstract

    Autogene cevumeran is an individualized neoantigen-specific therapy (iNeST) under development for the treatment of various solid tumors. It...

    Sebastian Guelman, Ying Zhou, ... Kun Peng in The AAPS Journal
    Article 02 May 2022
  5. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Specific and selective anti-CB 1 antibodies are among the most powerful research tools to unravel the complex biological processes mediated by the CB 1 ...

    Leyre Echeazarra, Gontzal García del Caño, ... Joan Sallés in Histochemistry and Cell Biology
    Article Open access 27 August 2021
  6. Application of the International System of Radiation Protection in Fit-for-Purpose Assessment of Impacts

    The fundamental safety objective is “to protect people and the environment from harmful effects of ionizing radiation” and this needs to be done...
    Conference paper 2022
  7. Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk

    Validation of key analytical and functional performance characteristics of in vitro immunogenicity risk assessment assays increases our confidence in...

    Dilki Wickramarachchi, Gregory Steeno, ... Li Xue in The AAPS Journal
    Article 24 August 2020
  8. Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial Sampling

    Purpose

    The purpose of this study was to validate a ligand binding assay for the quantitation of a monoclonal antibody-based biotherapeutics...

    Liang Zhu, Ying Wang, ... Boris Gorovits in Pharmaceutical Research
    Article 25 October 2019
  9. Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies

    Pharmacokinetic studies are key to evidence-based pharmacotherapy. The reliability of pharmacokinetic parameters is closely related to the quality of...

    Mohsin Ali, Jutta Tins, Bjoern B. Burckhardt in The AAPS Journal
    Article 04 September 2019
  10. Correction to: Fit-for-Purpose Quality Control System in Continuous Bioanalysis during Long-Term Pediatric Studies

    The LENA collaborator list below was not included in the original article.s

    Mohsin Ali, Jutta Tins, ... Eva Wissmann in The AAPS Journal
    Article 29 January 2020
  11. A Fit-for-Purpose Method for the Detection of Human Antibodies to Surface-Exposed Components of BMS-986263, a Lipid Nanoparticle-Based Drug Product Containing a siRNA Drug Substance

    ND-L02-s0201/BMS-986263 is a lipid nanoparticle (LNP) drug product containing a heat shock protein 47 (HSP47)–specific small interfering ribonucleic...

    Uma Kavita, Wendy Miller, ... Renuka C. Pillutla in The AAPS Journal
    Article 22 July 2019
  12. Develo** and Validating a Model of Humeral Stem Primary Stability, Intended for In Silico Clinical Trials

    In silico clinical trials (ISCT) can contribute to demonstrating a device’s performance via credible computational models applied on virtual cohorts....

    Ghislain Maquer, Christine Mueri, ... Philippe Favre in Annals of Biomedical Engineering
    Article 15 February 2024
  13. An industry perspective on current QSP trends in drug development

    2023 marks the 10th anniversary of Natpara’s submission to the US FDA, which led to the first recorded regulatory interaction where a decision was...

    Article Open access 05 March 2024
  14. Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and Manufacturing

    Cellular therapy development and manufacturing has focused on providing novel therapeutic cell-based products for various diseases. The International...

    Yongyang Huang, Rachel Watkins, ... Leo Li-Ying Chan in Journal of Fluorescence
    Article 22 September 2023
  15. Patient preferences for the design of a pharmacy-based colorectal cancer screening program

    Purpose

    To assess preferences for design of a pharmacy-based colorectal cancer (CRC) screening program (PharmFIT™) among screening-eligible adults in...

    Alison T. Brenner, Austin R. Waters, ... Parth D. Shah in Cancer Causes & Control
    Article Open access 19 April 2023
  16. Velocity loss is a flawed method for monitoring and prescribing resistance training volume with a free-weight back squat exercise

    Purpose

    The aim of this study was to examine the goodness of fit, prediction accuracy, and stability of general and individual relationships between...

    Ivan Jukic, Katarina Prnjak, ... Eric R. Helms in European Journal of Applied Physiology
    Article Open access 24 February 2023
  17. Developmental associations between cognition and adaptive behavior in intellectual and developmental disability

    Background

    Intellectual and developmental disabilities (IDDs) are associated with both cognitive challenges and difficulties in conceptual, social,...

    Andrew Dakopolos, Emma Condy, ... David Hessl in Journal of Neurodevelopmental Disorders
    Article Open access 13 June 2024
  18. A framework for establishing scientific confidence in new approach methodologies

    Robust and efficient processes are needed to establish scientific confidence in new approach methodologies (NAMs) if they are to be considered for...

    Anna J. van der Zalm, João Barroso, ... Amy J. Clip**er in Archives of Toxicology
    Article Open access 20 August 2022
  19. Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study

    Background and Objective

    Underdosing of adalimumab can result in non-response and poor disease control in patients with rheumatic disease or...

    Paul A. G. de Klaver, Ron J. Keizer, ... Luc J. J. Derijks in European Journal of Drug Metabolism and Pharmacokinetics
    Article 15 June 2023
Did you find what you were looking for? Share feedback.